Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 4, 2002, Pages 818-823

  Ribeiro Rodrigues, Rodrigo ^a   Co, Tatiana Resende ^a   Johnson, John L ^a   Ribeiro, Fabiola ^a   Palaci, Moises ^a   Sá, Ricardo T ^a   Maciel, Ethel L ^a   Pereira Lima, Fausto E ^a   Dettoni, Valderio ^a   Toossi, Zahra ^a   Boom, W Henry ^a   Dietze, Reynaldo ^a   Ellner, Jerrold J ^a   Hirsch, Christina S ^a  

^a Div of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; LUNG TUBERCULOSIS; MACROPHAGE; MALE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; PRIORITY JOURNAL; SPUTUM; T LYMPHOCYTE; ADOLESCENT; AGED; CASE CONTROL STUDY; CELL COUNT; CELLULAR IMMUNITY; CYTOLOGY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL COUNT; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036061920     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.4.818-823.2002     Document Type: Article

References (21)

1. Sputum phagocytes from healthy individuals are functional and activated: A flow cytometric comparison of cells in bronchoalveolar lavage and peripheral blood
2. Classification of pulmonary tuberculosis
3. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease
4. Neutrophil-derived proteins: Selling cytokines by the pound
5. Disseminated tuberculosis in IFN-γ gene-disrupted mice
6. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy
7. Induced sputum in patients with newly diagnosed sarcoidosis. Comparison with bronchial wash and BAL
8. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
9. An essential role for interferon-γ in resistance to M. tuberculosis
10. Impaired cutaneous wound healing in interleukin-deficient and immunosuppressed mice
11. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis
12. Apoptosis and T-cell hyporesponsiveness in pulmonary tuberculosis
13. Augmentation of apoptosis and IFN-γ production at sites of active MTB infection in human tuberculosis
14. Differences in IL-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
15. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human γδ-T cells: A mechanism for the loss of γδ-T cells in patients with pulmonary tuberculosis
16. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by cultures at 2 months
17. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF) alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis
18. T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis
19. Enhanced responses to M. tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis
20. Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis
21. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions